GLAMOROUS AI
Glamorous AI is a developer of an artificial intelligence-based drug discovery platform. The company's platform specializes in the research of medicines from the preceding experimental results, identifies and assimilates multiple subtle and complex compounds.
GLAMOROUS AI
Industry:
Artificial Intelligence Biotechnology Health Care Medical
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.glamorous.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Nginx Amazon Microsoft Azure DNS Amazon Route 53 Sectigo SSL
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Glamorous AI
Official Site Inspections
http://www.glamorous.ai Semrush global rank: 10.33 M Semrush visits lastest month: 4
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Glamorous AI"
Glamorous AI - PitchBook
Glamorous AI General Information Description. Developer of an artificial intelligence-based drug discovery platform intended to focus on low-data drug โฆSee details»
Noor Shaker - Wikipedia
Noor Shaker (Arabic: ููุฑ ุดุงูุฑ) is a Syrian British entrepreneur and computer scientist who co-founded the AI for drug discovery start-up Glamorous AI. Glamorous AI was acquired by the US-based company X-Chem in Nov 2021. Before Glamorous AI, Noor founded the drug discovery start-up GTN Ltd and was CEO for more than two years. She stepped down as CEO in August 2019โฆSee details»
X-Chem Acquires Glamorous AI โ Immediately Creating a Leader โฆ
Oct 28, 2021 Coupling X-Chemโs high-quality DEL data with the innovative AI capabilities of Glamorous AI positions X-Chem as a leading service provider in machine learning-driven drug โฆSee details»
GLAMOROUS.AI - LinkedIn
GLAMOROUS.AI | 3,037 followers on LinkedIn. First AI powered SaaS platform for drug discovery. Focusing on advancing AI to address data challenges. | GlamorousAI is bringing drugs to every target ...See details»
Glamorous AI - Funding, Financials, Valuation & Investors
Glamorous AI is a developer of an artificial intelligence-based drug discovery platform. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โฆSee details»
Glamorous AI - 2025 Company Profile - Tracxn
4 days ago Glamorous AI - Provider of preclinical studies on drug discovery for biopharma sector. Acquired by X-Chem. Raised funding from 2 investors. Founded by Noor Shaker in the โฆSee details»
Glamorous AI - Ownership and Business Overview - Mergr
Oct 28, 2021 Glamorous AI is a provider of artificial intelligence (AI) solutions for drug discovery. RosalindAI specializes in solving challenges inherent to sparse and noisy data sets that makes โฆSee details»
Glamorous AI - Updates, News, Events, Signals & Triggers
Jan 1, 2023 Glamorous AI is a developer of an artificial intelligence-based drug discovery platform. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... Experience โฆSee details»
Glamorous.AI - VentureRadar
Similar Companies: Xellar, Inc. USA Privately Held Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling โฆSee details»
GLAMOROUS AI LTD - Companies House
Charges for GLAMOROUS AI LTD (12516668) More for GLAMOROUS AI LTD (12516668) Registered office address 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, โฆSee details»
Glamorous AI - Products, Competitors, Financials, Employees ...
X-Chem Acquires Glamorous AI โ Immediately Creating a Leader in DEL-Powered AI Solutions. Nov 2, 2021. Combination Accelerates Outcomes in Early Drug Discovery WALTHAM, Mass.- โฆSee details»
X-Chem Announces Acquisition of Glamorous AI
Glamorous AI CEO Noor Shaker remarks, โX-Chem generates billions of high-quality data points with its DEL platform, and we provide the capability to build the best AI to unlock the power of โฆSee details»
Glamorous AI Careers, Perks + Culture - Built In
Learn more about Glamorous AI. Find jobs, explore benefits, and research company culture at Built In. Can't find your company? Create a company profile. ... Artificial Intelligence. Software. โฆSee details»
KQ Labs health accelerator announces first exit - LifeArc
Nov 1, 2021 The acquisition of the innovative AI capabilities of Glamorous AI positions X-Chem as a leading service provider in machine learning-driven drug discovery. Noor Shaker, CEO โฆSee details»
Glamorous.AI - Company info. interviews, news - BiopharmaTrend
GLAMOROUS AI has developed a novel approach to chemical design and optimization. Its proprietary platform, Rosalind, augments advanced ML with human expertise to enable โฆSee details»
X-Chem acquires Glamorous AI - 2021-10-28 - Crunchbase
Oct 28, 2021 X-Chem acquires Glamorous AI on 2021-10-28 for an undisclosed amount. New. Resources. Advanced Search. Start Free Trial ... Acquired Organization: Glamorous AI โฆSee details»
What is Glamorous AI? Company Culture, Mission, Values
See what employees say it's like to work at Glamorous AI. Salaries, reviews, and more - all posted by employees working at Glamorous AI.See details»
What leaders should know about โbring your own AIโ - MIT Sloan
Mar 11, 2025 To simplify AI access and encourage employee use, Zoetis set up a generative AI app store in which employees can apply for tool licenses and learn about effective and โฆSee details»
How COOs maximize operational impact from gen AI and agentic AI
Mar 20, 2025 To an even greater degree than seen in earlier waves of technology-based transformation, gen AI touches virtually every part of a business organization. This expanded โฆSee details»
Goldman Sachs' Marco Argenti Said Companies Must Embed โฆ
23 hours ago Goldman Sachs' Marco Argenti said businesses need to integrate company culture into AI agents. The tech industry has mostly focused on the "specialization of expertise," he โฆSee details»